Facebook-f

Vegzelma (Bevacizumab) : US-FDA approved biosimilar to Avastin (Bevacizumab).

It is successfully use in the following eye diseases conditions.

  • Neovascular (wet) age-related macular degeneration.

  • Macular edema following retinal vein occlusion.

  • Diabetic macular edema.

  • Proliferative diabetic retinopathy.

  • Neovascular glaucoma.

  • Diabetic retinopathy associated with ocular neovascularization.

Download Leaflet

Corporate HQ:

9th Floor, Navana Zohura Square, 6 Mymensingh Ln, Banglamotor, Dhaka, – 1000, Bangladesh.

Copyright @ all right reserved by ZAS Ophthalmic
Scroll to Top